The Rwei Group engineers smart therapeutic and diagnostic platforms for next-generation precision therapies. Our long-term research goal is to bridge clinical translation with scientific discoveries by interfacing biology, materials science, and engineering in biomedical innovations that will make a long-lasting impact in patients’ lives. Current fields of reseach include: A) externally-triggerable liposomes for alleviating pain and combatting cancer. B) wearable biosensors for non-invasive, personalized, and real-time monitoring of patients' health state.
Contact Person
Dr. Alina Rwei
